Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Viatris Inc (VTRSV) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Viatris Inc (VTRSV) lobbying for?
Summary of Lobbying Data:
Company: Viatris Inc.
Lobbying Firms: Viatris Inc., Holland & Knight Llp, Rampy Northrup Llc
General Issues Lobbied: Taxation/Internal Revenue Code, Pharmacy, Health Issues, Financial Institutions/Investments/Securities, Veterans, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations
Specific Issues Lobbied: Prescription Drug Pricing Dashboard Act (S. 1773); drug pricing; Enhanced Access to Affordable Medicines Act of 2022 (H.R. 6973); Increasing Transparency in Generic Drug Applications Act of 2022 (H.R. 7032); Generic Drug User Fee Amendments; FY 2023 Omnibus Appropriations Bill., Increasing Transparency in Generic Drug Applications Act of 2022, Consolidated Appropriations Act, and Related Agencies appropriations bill (H.R. 4355), e-labeling provision in the FY2022 Agriculture, Prescription Drug Pricing Dashboard Act (S. 1773); drug pricing; Build Back Better Act (H.R. 5376); Enhanced Access to Affordable Medicines Act of 2022 (H.R. 6973); Increasing Transparency in Generic Drug Applications Act of 2022 (H.R. 7032); Generic Drug User Fee Amendments., Medicare Part D program and generic drugs H.R. 2846 – Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 – the Inflation Reduction Act of 2022; S. 4348 – the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 – the Food and Drug Amendments of 2022; H.R. 8239 – Making appropriations for Agriculture, Enhanced Access to Affordable Medicines Act of 2022; H.R.7032/S.4338, Legislation and regulations related to pharmaceuticals and medical products, Medicare Part D program and generic drugs H.R. 2846 – Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 – Build Back Better Act; Part D Formulary Design and Generic Drug Tiering S. 4348 – the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 – the Food and Drug Amendments of 2022; H.R. 8239 – Making appropriations for Agriculture, generic drugs issues, and for other purposes.
Government Agencies Lobbied: Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), House of Representatives, Food & Drug Administration (FDA), Department of Health & Human Services (HHS), Senate, Centers For Medicare and Medicaid Services (CMS), Department of Commerce (DOC)
One could infer that Viatris Inc. is lobbying on these issues to shape the policies and regulations around the pharmaceutical industry to benefit their business interests, specifically with regards to increasing access to lower-cost medicines, ensuring quality, and reducing regulations that hinder their operations or impact their profits. They are also seeking to influence government spending bills and appropriations to secure funding for their initiatives and research. The specific government agencies they lobbied show that they are focused on shaping policy across various levels of government to achieve their goals.
